164 related articles for article (PubMed ID: 32456486)
21. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
22. Accelerated age-related CpG island methylation in ulcerative colitis.
Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
[TBL] [Abstract][Full Text] [Related]
23. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
Parang B; Kaz AM; Barrett CW; Short SP; Ning W; Keating CE; Mittal MK; Naik RD; Washington MK; Revetta FL; Smith JJ; Chen X; Wilson KT; Brand T; Bader DM; Tansey WP; Chen R; Brentnall TA; Grady WM; Williams CS
Gut; 2017 May; 66(5):852-862. PubMed ID: 28389570
[TBL] [Abstract][Full Text] [Related]
24. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis.
Kim TO; Park J; Kang MJ; Lee SH; Jee SR; Ryu DY; Yang K; Yi JM
Int J Mol Med; 2013 May; 31(5):1255-61. PubMed ID: 23546389
[TBL] [Abstract][Full Text] [Related]
25. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
26. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
27. Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era.
Gui X; Iacucci M; Ghosh S; Ferraz JGP; Lee S
Hum Pathol; 2020 Jun; 100():24-37. PubMed ID: 32387105
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas.
Odze RD; Brown CA; Hartmann CJ; Noffsinger AE; Fogt F
Am J Surg Pathol; 2000 Sep; 24(9):1209-16. PubMed ID: 10976694
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status.
Saito S; Kato J; Hiraoka S; Horii J; Suzuki H; Higashi R; Kaji E; Kondo Y; Yamamoto K
Inflamm Bowel Dis; 2011 Sep; 17(9):1955-65. PubMed ID: 21830274
[TBL] [Abstract][Full Text] [Related]
30. [Intraepithelial neoplasia/dysplasia - histopathology in ulcerative colitis].
Baretton GB; Aust DE
Pathologe; 2008 Nov; 29 Suppl 2():280-5. PubMed ID: 18820923
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis.
Suzuki K; Muto T; Shinozaki M; Yokoyama T; Matsuda K; Masaki T
Dis Colon Rectum; 1998 Mar; 41(3):322-7. PubMed ID: 9514427
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
33. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: genetic approach to the differential diagnosis (review).
Fogt F; Alsaigh N
Oncol Rep; 1999; 6(4):721-5. PubMed ID: 10373645
[TBL] [Abstract][Full Text] [Related]
34. The histologic diagnosis of dysplasia, dysplasia-associated lesion or mass, and adenoma: a pathologist's perspective.
Goldblum JR
J Clin Gastroenterol; 2003; 36(5 Suppl):S63-9; discussion S94-6. PubMed ID: 12702968
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of polypoid lesions in inflammatory bowel disease.
Chawla A; Judge TA; Lichtenstein GR
Gastrointest Endosc Clin N Am; 2002 Jul; 12(3):525-34, ix. PubMed ID: 12486942
[TBL] [Abstract][Full Text] [Related]
36. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
38. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
40. Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Kmiya Y; Ishizuka T; Fujita H; Nagasaka M; Yamada H; Hirata I; Arisawa T
Anticancer Res; 2011 Mar; 31(3):933-8. PubMed ID: 21498716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
